Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: Results of the phase 3 ARCON trial

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. Fu, Thomas F. Pajak, Andy Trotti et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.4K citations

Medicine, Oncology, Radiation Oncology +17

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines

Vincent Grégoire, Peter C. Levendag, Kian Ang et al. · Radiotherapy and Oncology · 2003 · 680 citations · Full text

Medicine, Oncology, Radiology +17

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

Jens Overgaard, Hanne Sand Hansen, Lena Specht et al. · The Lancet · 2003 · 673 citations

Medicine, Oncology, Radiation Oncology +7

HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity

Thorsten Rieckmann, Silke Tribius, Tobias Grob et al. · Radiotherapy and Oncology · 2013 · 312 citations

Medicine, Cell Biology, Oncology +14

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial

Geert O. Janssens, Saskia E. Rademakers, Chris H.J. Terhaard et al. · Journal of Clinical Oncology · 2012 · 252 citations · Full text

Medicine, Oncology, Radiation Oncology +14